VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NRIX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NRIXNurix Therapeutics, Inc.
$15.30$1.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNRIXQuarterly Financials

Nurix Therapeutics, Inc. (NRIX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Nurix Therapeutics, Inc. (NRIX) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

NRIX Income Statement

Quarterly statement

NRIX Income Statement

Nurix Therapeutics, Inc. (NRIX) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue673.06M9.04M6.25M13.58M7.89M44.06M18.45M13.28M12.59M12.09M16.59M15.16M18.47M30.68M12.69M6.78M10.79M11.43M9.62M7.4M
Revenue Growth %8426.27%-79.47%-66.12%2.21%-37.29%264.34%11.26%-12.37%-31.84%-60.58%30.75%123.49%71.13%168.33%31.85%-8.29%5.26%61.22%92%10.57%
Cost of Goods Sold2.14M3.85M84.14M4.63M5M78.1M69.66M67.22M55.48M48.92M50.01M49.71M47.86M45.76M45.82M46.11M47.76M47.49M43.14M36.53M
COGS % of Revenue0.32%42.57%1345.76%34.11%63.34%177.27%377.52%506.05%440.75%404.58%301.51%327.94%259.14%149.18%361.18%679.73%442.6%415.44%448.36%493.93%
Gross Profit670.92M5.19M-77.89M8.95M2.89M-34.04M-51.21M-53.94M-42.89M-36.83M-33.42M-34.55M-29.39M-15.09M-33.13M-39.32M-36.97M-36.06M-33.52M-29.14M
Gross Margin %99.68%57.43%-1245.76%65.89%36.66%-77.27%-277.52%-406.05%-340.75%-304.58%-201.51%-227.94%-159.14%-49.18%-261.18%-579.73%-342.6%-315.44%-348.36%-393.93%
Gross Profit Growth %23083.31%115.26%-52.09%116.59%106.75%7.58%-53.23%-56.1%-45.95%-144.12%-0.87%12.13%20.51%58.16%1.15%-34.97%-79%-90.77%-86.28%-111.8%
Operating Expenses111.47M99.4M14.61M92.04M94.28M14.28M11.65M10.72M11.72M11.71M11.8M10.78M10.62M11.68M9.82M9.37M9.75M9.65M9.23M8.82M
OpEx % of Revenue16.56%1099.16%233.69%677.92%1194.31%32.42%63.15%80.68%93.09%96.84%71.14%71.11%57.52%38.07%77.42%138.1%90.33%84.45%95.92%119.23%
Selling, General & Admin34.35M15.59M14.61M13.65M13.16M14.28M11.65M10.72M11.72M11.71M11.8M10.78M10.62M11.68M9.82M9.37M9.75M9.65M9.23M8.82M
SG&A % of Revenue5.1%172.44%233.69%100.52%166.7%32.42%63.15%80.68%93.09%96.84%71.14%71.11%57.52%38.07%77.42%138.1%90.33%84.45%95.92%119.23%
Research & Development79.26M87.65M84.14M80.9M86.12M78.1M69.66M67.22M55.48M48.92M50.01M49.71M47.86M45.76M45.82M46.11M47.76M47.49M43.14M36.53M
R&D % of Revenue11.78%969.29%1345.76%595.89%1090.96%177.27%377.52%506.05%440.75%404.58%301.51%327.94%259.14%149.18%361.18%679.73%442.6%415.44%448.36%493.93%
Other Operating Expenses-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income559.45M-94.2M-92.5M-83.09M-91.39M-48.32M-62.86M-64.66M-54.61M-48.54M-45.22M-45.33M-40.01M-26.77M-42.95M-48.69M-46.72M-45.72M-42.74M-37.95M
Operating Margin %83.12%-1041.73%-1479.45%-612.03%-1157.65%-109.68%-340.67%-486.73%-433.83%-401.42%-272.65%-299.06%-216.67%-87.25%-338.6%-717.82%-432.93%-399.89%-444.28%-513.16%
Operating Income Growth %712.19%-94.95%-47.14%-28.52%-67.34%0.45%-39.02%-42.62%-36.49%-81.36%-5.28%6.89%14.35%41.45%-0.49%-28.29%-61.11%-73.07%-74.31%-89.69%
EBITDA561.59M-90.35M-88.72M-78.46M-86.39M-43.23M-58.74M-60.35M-50.47M-44.45M-43.17M-44.8M-38.06M-24.87M-41.2M-48.27M-45.26M-44.43M-41.75M-37.2M
EBITDA Margin %83.44%-999.16%-1419.05%-577.92%-1094.31%-98.11%-318.3%-454.34%-400.9%-367.59%-260.32%-295.53%-206.1%-81.07%-324.79%-711.65%-419.43%-388.67%-433.98%-502.92%
EBITDA Growth %750.1%-109.03%-51.05%-30.01%-71.18%2.75%-36.04%-34.72%-32.59%-78.73%-4.79%7.19%15.91%44.03%1.32%-29.77%-60.2%-72.43%-74.85%-92.09%
D&A (Non-Cash Add-back)2.14M3.85M3.78M4.63M5M5.1M4.13M4.3M4.15M4.09M2.04M534K1.95M1.9M1.75M419K1.46M1.28M991K757K
EBIT563.41M-89.81M-87.17M-78.22M-86.42M-42.7M-56.35M-58.54M-48.87M-44.46M-41.43M-41.96M-36.98M-24.28M-40.73M-46.72M-45.71M-45.4M-42.53M-37.66M
Net Interest Income3.96M4.4M5.32M4.87M4.96M5.62M6.51M6.12M5.74M4.08M3.79M3.38M3.03M2.49M2.22M1.97M1.01M314K211K295K
Interest Income3.96M4.4M5.32M4.87M4.96M5.62M6.51M6.12M5.74M4.08M3.79M3.38M3.03M2.49M2.22M1.97M1.01M314K211K295K
Interest Expense00000000000000000000
Other Income/Expense3.96M4.4M5.32M4.87M4.96M5.62M6.51M6.12M5.74M4.08M3.79M3.38M3.03M2.49M2.22M1.97M1.01M314K211K295K
Pretax Income563.41M-89.81M-87.17M-78.22M-86.42M-42.7M-56.35M-58.54M-48.87M-44.46M-41.43M-41.96M-36.98M-24.28M-40.73M-46.72M-45.71M-45.4M-42.53M-37.66M
Pretax Margin %83.71%-993.1%-1394.34%-576.13%-1094.77%-96.93%-305.38%-440.69%-388.26%-367.65%-249.79%-276.77%-200.26%-79.14%-321.11%-688.74%-423.58%-397.14%-442.08%-509.17%
Income Tax13.61M-271K000760K08K82K90K90K0000000044K
Effective Tax Rate %2.41%0.3%0%0%0%-1.78%0%-0.01%-0.17%-0.2%-0.22%0%0%0%0%0%0%0%0%-0.12%
Net Income549.81M-89.53M-87.17M-78.22M-86.42M-43.46M-56.35M-58.55M-48.96M-44.55M-41.52M-41.96M-36.98M-24.28M-40.73M-46.72M-45.71M-45.4M-42.53M-37.7M
Net Margin %81.69%-990.1%-1394.34%-576.13%-1094.77%-98.66%-305.38%-440.75%-388.91%-368.39%-250.33%-276.77%-200.26%-79.14%-321.11%-688.74%-423.58%-397.14%-442.08%-509.76%
Net Income Growth %736.2%-106%-54.7%-33.6%-76.53%2.43%-35.73%-39.55%-32.38%-83.49%-1.93%10.19%19.09%46.53%4.23%-23.91%-58.52%-72.09%-75.21%-89.32%
Net Income (Continuing)549.81M-89.53M-87.17M-78.22M-86.42M-43.46M-56.35M-58.55M-48.96M-44.55M-41.52M-41.96M-36.98M-24.28M-40.73M-46.72M-45.71M-45.4M-42.53M-37.7M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)4.73-0.81-0.79-0.82-1.03-0.52-0.67-0.75-0.67-0.71-0.76-0.77-0.68-0.40-0.65-0.77-0.88-1.00-0.95-0.85
EPS Growth %559.22%-55.77%-17.91%-9.33%-53.73%26.76%11.84%2.6%1.47%-77.5%-16.92%0%22.73%60%31.58%9.41%-35.38%-66.67%-50.79%-66.67%
EPS (Basic)4.93-0.81-0.79-0.82-1.03-0.52-0.67-0.75-0.67-0.71-0.76-0.77-0.68-0.40-0.65-0.77-0.88-1.00-0.95-0.85
Diluted Shares Outstanding116.15M111.08M110.07M95.09M84.16M83.88M83.56M78.41M72.78M62.38M54.9M54.67M54.39M54.26M54.03M53.94M50.87M44.9M44.69M44.55M
Basic Shares Outstanding111.56M111.08M110.07M95.09M84.16M83.88M83.56M78.41M72.78M62.38M54.9M54.67M54.39M54.26M54.03M53.94M50.87M44.9M44.69M44.55M
Dividend Payout Ratio--------------------